These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8568800

  • 1. Structure-antigastrin activity relationships of new spiroglumide amido acid derivatives.
    Makovec F, Peris W, Frigerio S, Giovanetti R, Letari O, Mennuni L, Revel L.
    J Med Chem; 1996 Jan 05; 39(1):135-42. PubMed ID: 8568800
    [Abstract] [Full Text] [Related]

  • 2. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
    Letari O, Mennuni L, Revel L, Colombo S, Makovec F.
    Eur J Pharmacol; 1996 Jun 13; 306(1-3):325-33. PubMed ID: 8813647
    [Abstract] [Full Text] [Related]

  • 3. Structure-antigastrin activity relationships of new (R)-4-benzamido-5-oxopentanoic acid derivatives.
    Makovec F, Peris W, Revel L, Giovanetti R, Mennuni L, Rovati LC.
    J Med Chem; 1992 Jan 13; 35(1):28-38. PubMed ID: 1732532
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS, Chen TB, Bock MG, Freidinger RM, Chen R, Rosegay A, Lotti VJ.
    Mol Pharmacol; 1989 Jun 13; 35(6):803-8. PubMed ID: 2733696
    [Abstract] [Full Text] [Related]

  • 5. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
    Makovec F, Revel L, Letari O, Mennuni L, Impicciatore M.
    Eur J Pharmacol; 1999 Mar 12; 369(1):81-90. PubMed ID: 10204685
    [Abstract] [Full Text] [Related]

  • 6. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

  • 7. Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist.
    Fukamizu Y, Nakajima T, Kimura K, Kanda H, Fujii M, Saito T, Kasai H.
    Arzneimittelforschung; 1998 Jan 28; 48(1):58-64. PubMed ID: 9522034
    [Abstract] [Full Text] [Related]

  • 8. Effect of dexloxiglumide and spiroglumide, two new CCK-receptor antagonists, on gastric emptying and secretion in the rat: evaluation of their receptor selectivity in vivo.
    Scarpignato C, Kisfalvi I, D'Amato M, Varga G.
    Aliment Pharmacol Ther; 1996 Jun 28; 10(3):411-9. PubMed ID: 8791971
    [Abstract] [Full Text] [Related]

  • 9. RP 73870, a gastrin/cholecystokinin-B receptor antagonist with potent anti-ulcer activity in the rat.
    Pendley CE, Fitzpatrick LR, Capolino AJ, Davis MA, Esterline NJ, Jakubowska A, Bertrand P, Guyon C, Dubroeucq MC, Martin GE.
    J Pharmacol Exp Ther; 1995 Jun 28; 273(3):1015-22. PubMed ID: 7791071
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
    Bertrand P, Böhme GA, Durieux C, Guyon C, Capet M, Jeantaud B, Boudeau P, Ducos B, Pendley CE, Martin GE.
    Eur J Pharmacol; 1994 Sep 12; 262(3):233-45. PubMed ID: 7813588
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists.
    Makovec F, Bani M, Cereda R, Chisté R, Pacini MA, Revel L, Rovati LA, Rovati LC, Setnikar I.
    Arzneimittelforschung; 1987 Nov 12; 37(11):1265-8. PubMed ID: 3440035
    [Abstract] [Full Text] [Related]

  • 12. Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors.
    Gully D, Fréhel D, Marcy C, Spinazzé A, Lespy L, Neliat G, Maffrand JP, Le Fur G.
    Eur J Pharmacol; 1993 Feb 23; 232(1):13-9. PubMed ID: 7681406
    [Abstract] [Full Text] [Related]

  • 13. Lorglumide and loxiglumide inhibit gastrin-stimulated DNA synthesis in a rat tumoral acinar pancreatic cell line (AR42J).
    Seva C, Scemama JL, Bastié MJ, Pradayrol L, Vaysse N.
    Cancer Res; 1990 Sep 15; 50(18):5829-33. PubMed ID: 2393852
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and stereochemical structure-activity relationships of 1,3-dioxoperhydropyrido[1,2-c]pyrimidine derivatives: potent and selective cholecystokinin-A receptor antagonists.
    Martín-Martínez M, Bartolomé-Nebreda JM, Gómez-Monterrey I, González-Muñiz R, García-López MT, Ballaz S, Barber A, Fortuño A, Del Río J, Herranz R.
    J Med Chem; 1997 Oct 10; 40(21):3402-7. PubMed ID: 9341915
    [Abstract] [Full Text] [Related]

  • 15. (3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist.
    Semple G, Ryder H, Rooker DP, Batt AR, Kendrick DA, Szelke M, Ohta M, Satoh M, Nishida A, Akuzawa S, Miyata K.
    J Med Chem; 1997 Jan 31; 40(3):331-41. PubMed ID: 9022799
    [Abstract] [Full Text] [Related]

  • 16. Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig.
    Morini G, Barocelli E, Impicciatore M, Grider JR, Makhlouf GM.
    Regul Pept; 1990 May 21; 28(3):313-21. PubMed ID: 2377745
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological and biochemical evidence for the simultaneous expression of CCKB/gastrin and CCKA receptors in the pig pancreas.
    Philippe C, Lhoste EF, Dufresne M, Moroder L, Corring T, Fourmy D.
    Br J Pharmacol; 1997 Feb 21; 120(3):447-54. PubMed ID: 9031748
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonist.
    Setnikar I, Bani M, Cereda R, Chisté R, Makovec F, Pacini MA, Revel L, Rovati LC, Rovati LA.
    Arzneimittelforschung; 1987 Jun 21; 37(6):703-7. PubMed ID: 3663268
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. II.
    Takeda Y, Kawagoe K, Yokomizo A, Yokomizo Y, Hosokami T, Shimoto Y, Tabuchi Y, Ogihara Y, Otsubo R, Honda Y, Yokohama S.
    Chem Pharm Bull (Tokyo); 1998 Jun 21; 46(6):951-61. PubMed ID: 9658573
    [Abstract] [Full Text] [Related]

  • 20. Different actions of CCK on pancreatic and gastric growth in the rat: effect of CCK(A) receptor blockade.
    Varga G, Kisfalvi K, Pelosini I, D'Amato M, Scarpignato C.
    Br J Pharmacol; 1998 Jun 21; 124(3):435-40. PubMed ID: 9647465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.